Description
The abstract mentions RNA sequencing identified 4 enriched pathways but cuts off before revealing them. These pathways could provide crucial insights into the molecular mechanisms underlying the therapeutic effects and guide future intervention strategies.
Gap type: open_question Source paper: Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model. (None, None, PMID:36575534)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:50.021646+00:00”, “resolution_summary”: “Resolved by hypothesis h-c34258ddeb: Perturbation-first validation should precede therapeutic claims for Biophysical Determinants Shifting FUS/TDP-43 Phase Separation to Pathological Aggregates. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-c34258ddeb”, “title”: “Perturbation-first validation should precede therapeutic claims for Biophysical Determinants Shifting FUS/TDP-43 Phase Separation to Pathological Aggregates”, “score”: 0.36, “reason”: “4 token overlaps; entity overlap: fus, rna”, “analysis_id”: “52661eaf-79f8-4647-8f48-3389f5af4d59”, “target_gene”: “RNA”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.608, “confidence_score”: 0.55, “status”: “proposed”, “pubmed_evidence_ids”: []}, {“id”: “h-6756097b”, “title”: “ASO-Mediated Exon Skipping to Restore FUS-TAZ Chaperone Axis”, “score”: 0.308, “reason”: “12 token overlaps; entity overlap: fus, rna”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “target_gene”: “FUS”, “target_pathway”: “RNA processing / FUS/TLS function”, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.68, “status”: “promoted”, “pubmed_evidence_ids”: [“26799652”, “29677512”, “31630970”, “37974279”, “38031260”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “title”: “The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn’t address how FUS mutations in ALS/FTD might disrupt this function. This gap is critical since FUS mutations cause neurodegeneration, yet this newly discovered role in transcriptional regulation remains unexplored in disease context.\n\nGap type: open_question\nSource paper: A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation. (None, None, PMID:38172614)”, “score”: 0.476, “reason”: “8 token overlaps; entity overlap: fus, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2_task_9aae8fc5”, “title”: “The review covers various organelle-specific autophagy types but doesn’t address what molecular mechanisms determine which organelles are selectively targeted for autophagy in neurodegeneration. This selectivity mechanism is crucial for understanding disease progression and therapeutic intervention.\n\nGap type: open_question\nSource paper: Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. (2021, Autophagy, PMID:32048886)”, “score”: 0.429, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2”, “quality_score”: 0.655, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5”, “title”: “While the abstract identifies AQP4 as a ‘potential and promising target’ and mentions it could provide ‘new therapeutic alternatives,’ the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention.\n\nGap type: open_question\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.415, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193701-11582758_20260416-035652”, “title”: “The abstract reveals contradictory evidence where clusterin is proposed as a protective chaperone protein, yet knockout studies show it exacerbates neuronal death in hypoxia-ischemia. This fundamental contradiction undermines therapeutic targeting strategies.\n\nGap type: contradiction\nSource paper: Clusterin. (None, None, PMID:11906815)”, “score”: 0.377, “reason”: “8 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193701-11582758”, “quality_score”: 0.72, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.372, “reason”: “8 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}